{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:58:08Z","timestamp":1787504288627,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,22]],"date-time":"2027-01-22T00:00:00Z","timestamp":1800576000000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["2R44NS107079-02A1"],"award-info":[{"award-number":["2R44NS107079-02A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1SB1NS135733-01"],"award-info":[{"award-number":["1SB1NS135733-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymgme.2026.109733","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:07:27Z","timestamp":1768583247000},"page":"109733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier"],"prefix":"10.1016","volume":"147","author":[{"given":"Renuka","family":"Raman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shahrokh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Hatambeygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Leszczyniecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.109733_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","article-title":"Current and emerging treatment strategies for neuronal ceroid lipofuscinoses","volume":"33","author":"Kohlschutter","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ymgme.2026.109733_bb0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI3112","article-title":"Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S","volume":"102","author":"Das","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2026.109733_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.1103","article-title":"Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease","volume":"50","author":"van Diggelen","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2026.109733_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1212\/01.wnl.0000252825.85947.2f","article-title":"Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1","volume":"68","author":"Ramadan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.109733_bb0025","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","article-title":"Towards a new understanding of NCL pathogenesis","volume":"1852","author":"Cooper","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2026.109733_bb0030","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1073\/pnas.93.19.10046","article-title":"Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase","volume":"93","author":"Lu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2026.109733_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pediatrneurol.2021.04.002","article-title":"Management of CLN1 disease: international clinical consensus","volume":"120","author":"Augustine","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2026.109733_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2012.05.009","article-title":"Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis","volume":"107","author":"Hu","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109733_bb0045","doi-asserted-by":"crossref","first-page":"E5920","DOI":"10.1073\/pnas.1701832114","article-title":"Synergistic effects of treating the spinal cord and brain in CLN1 disease","volume":"114","author":"Shyng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2026.109733_bb0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ymgme.2009.12.002","article-title":"Human recombinant palmitoyl-protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis","volume":"99","author":"Lu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109733_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001590","article-title":"Identification of substrates of palmitoyl protein thioesterase 1 highlights roles of depalmitoylation in disulfide bond formation and synaptic function","volume":"20","author":"Gorenberg","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymgme.2026.109733_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163107","article-title":"Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep","volume":"132","author":"Nelvagal","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2026.109733_bb0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/376584a0","article-title":"Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis","volume":"376","author":"Vesa","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2026.109733_bb0070","doi-asserted-by":"crossref","first-page":"23212","DOI":"10.1016\/S0021-9258(17)31641-1","article-title":"Molecular cloning and expression of palmitoyl-protein thioesterase","volume":"269","author":"Camp","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2026.109733_bb0075","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1073\/pnas.080508097","article-title":"The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis","volume":"97","author":"Bellizzi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2026.109733_bb0080","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/hmg\/10.13.1431","article-title":"Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis","volume":"10","author":"Das","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.109733_bb0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2121-8-22","article-title":"Glycosylation, transport, and complex formation of palmitoyl protein thioesterase 1 (PPT1)--distinct characteristics in neurons","volume":"8","author":"Lyly","year":"2007","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.ymgme.2026.109733_bb0090","article-title":"Intrathecal delivery of protein therapeutics to treat genetic diseases involving the CNS","volume":"16-20","author":"Shahrokh","year":"2010","journal-title":"ONdrugDelivery"},{"key":"10.1016\/j.ymgme.2026.109733_bb0095","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1038\/s41598-018-26913-4","article-title":"Lysosomal targeting enhancement by conjugation of glycopeptides containing Mannose-6-phosphate glycans derived from Glyco-engineered yeast","volume":"8","author":"Kang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2026.109733_bb0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/j.1460-2075.1989.tb03426.x","article-title":"Regulation of the mannose 6-phosphate\/IGF II receptor expression at the cell surface by mannose 6-phosphate, insulin like growth factors and epidermal growth factor","volume":"8","author":"Braulke","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2026.109733_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/jcbfm.1983.2","article-title":"Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes","volume":"3","author":"Blasberg","year":"1983","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ymgme.2026.109733_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data","volume":"3","author":"Patlak","year":"1983","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ymgme.2026.109733_bb0115","doi-asserted-by":"crossref","first-page":"2292461","DOI":"10.1080\/21688370.2023.2292461","article-title":"Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"12","author":"Rhea","year":"2024","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ymgme.2026.109733_bb0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood-brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.ymgme.2026.109733_bb0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ymgme.2026.109733_bb0130","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0405042101","article-title":"Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier","volume":"101","author":"Urayama","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2026.109733_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142347","article-title":"Alpha adrenergic induction of transport of lysosomal enzyme across the blood-brain barrier","volume":"10","author":"Urayama","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2026.109733_bb0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/jnt4040020","article-title":"Enhancing antibody exposure in the central nervous system: mechanisms of uptake, clearance, and strategies for improved brain delivery","volume":"4","author":"Schwinghamer","year":"2023","journal-title":"J Nanotheranostics"},{"key":"10.1016\/j.ymgme.2026.109733_bb0145","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1046\/j.1471-4159.1994.62062404.x","article-title":"Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin, and albumin: pharmacokinetic and morphological assessments","volume":"62","author":"Banks","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2026.109733_bb0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O","article-title":"Characterization of lectin-mediated brain uptake of HIV-1 GP120","volume":"54","author":"Banks","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2026.109733_bb0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2015.05.005","article-title":"Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis","volume":"116","author":"Lu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109733_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128986","article-title":"Pharmacokinetics of novel plant cell-expressed Taliglucerase alfa in adult and Pediatric patients with Gaucher disease","volume":"10","author":"Abbas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2026.109733_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4155\/cli.10.21","article-title":"Velaglucerase alfa in the treatment of Gaucher disease type 1","volume":"1","author":"Burrow","year":"2011","journal-title":"Clin Investig (Lond)"},{"key":"10.1016\/j.ymgme.2026.109733_bb0170","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/cts.13652","article-title":"Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolism","volume":"16","author":"Hon","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ymgme.2026.109733_bb0175","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/cpdd.1314","article-title":"Pharmacokinetics of Alglucosidase alfa manufactured at the 4000-L scale in participants with Pompe disease: aphase 3\/4 open-label study","volume":"12","author":"Nicolas","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.ymgme.2026.109733_bb0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/GIM.0b013e318133fb1b","article-title":"The pharmacology of multiple regimens of agalsidase alfa enzyme replacement therapy for Fabry disease","volume":"9","author":"Clarke","year":"2007","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.109733_bb0185","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI118617","article-title":"Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome","volume":"97","author":"Crawley","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2026.109733_bb0190","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMp048084","article-title":"Advances in the treatment of mucopolysaccharidosis type I","volume":"350","author":"Muenzer","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.109733_bb0195","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/stem.163","article-title":"Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease","volume":"27","author":"Jeyakumar","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymgme.2026.109733_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040509","article-title":"Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification","volume":"7","author":"Meng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2026.109733_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030341","article-title":"CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder","volume":"7","author":"Calias","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2026.109733_bb0210","doi-asserted-by":"crossref","first-page":"16733","DOI":"10.1016\/S0021-9258(19)84766-X","article-title":"Developmental expression of the tissue insulin-like growth factor II\/mannose 6-phosphate receptor in the rat. Measurement by quantitative immunoblotting","volume":"264","author":"Sklar","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2026.109733_bb0215","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1210\/endo-124-2-1064","article-title":"Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle","volume":"124","author":"Alexandrides","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymgme.2026.109733_bb0220","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0705611104","article-title":"Epinephrine enhances lysosomal enzyme delivery across the blood brain barrier by up-regulation of the mannose 6-phosphate receptor","volume":"104","author":"Urayama","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2026.109733_bb0225","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/0271678X15614589","article-title":"Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier","volume":"36","author":"Urayama","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ymgme.2026.109733_bb0230","doi-asserted-by":"crossref","first-page":"15831","DOI":"10.1074\/jbc.271.26.15831","article-title":"Lysosomal targeting of palmitoyl-protein thioesterase","volume":"271","author":"Verkruyse","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2026.109733_bb0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fncel.2019.00092","article-title":"The interactome of palmitoyl-protein Thioesterase 1 (PPT1) affects neuronal morphology and function","volume":"13","author":"Sapir","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymgme.2026.109733_bb0240","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cne.10492","article-title":"Palmitoyl protein thioesterase 1 is targeted to the axons in neurons","volume":"455","author":"Ahtiainen","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymgme.2026.109733_bb0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/10.1.69","article-title":"Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL)","volume":"10","author":"Lehtovirta","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.109733_bb0250","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163107","article-title":"Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep","volume":"132","author":"Nelvagal","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2026.109733_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-43650-z","article-title":"Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice","volume":"15","author":"Ni","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2026.109733_bb0260","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.109733_bb0265","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2026.109733_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413633","article-title":"Investigating the Endo-lysosomal system in major neurocognitive disorders due to Alzheimer\u2019s disease, frontotemporal lobar degeneration and Lewy body disease: evidence for SORL1 as a cross-disease gene","volume":"22","author":"Benussi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.109733_bb0275","unstructured":"N. P. Taylor, in Fierce Biotech (2022), vol. 2022."},{"key":"10.1016\/j.ymgme.2026.109733_bb0280","unstructured":"N. P. Taylor. (Fierce Biotech, 2022)."},{"key":"10.1016\/j.ymgme.2026.109733_bb0285","article-title":"Treatment of CLN1 disease with a blood-brain barrier penetrating lysosomal enzyme","volume":"33","author":"Hahn","year":"2022","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.ymgme.2026.109733_bb0290","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/13543784.2020.1837110","article-title":"Batten disease: an expert update on agents in preclinical and clinical trials","volume":"29","author":"Masten","year":"2020","journal-title":"Expert Opin. Investig. Drugs"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226000168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226000168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:38:26Z","timestamp":1776170306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226000168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1096719226000168"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109733","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109733"}}